Internal Medicine, Rheumatology · Bayamon, PR
NPI
1235278516
Since 2007
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
Edificio Medico Santa Cruz, 73 Calle Santa Cruz- Ofic 216
Bayamon, PR, 00961
Phone (787) 787-0202
Medicare paid, 2024
$2,187
55 services
Medicare patients, 2024
26
Average age 76
Drug cost, 2024
$3.5M
5,638 prescriptions
Company payments, 2025
$49.4
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Elena Velazquez-Ortiz was code 99213 (office e&m - established), 50 times for 25 patients. In total Elena Velazquez-Ortiz billed 55 services in 3 codes, and Medicare paid $2,187.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-08-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 50 | 25 | $36.57 | $1,829 |
By year: 2022 $3,587 for 93 services; 2023 $3,762 for 96 services; 2024 $2,187 for 55 services.
Medicare prescription drug claims, 2024
In 2024, the drug Elena Velazquez-Ortiz prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 678 prescriptions and refills. In total Elena Velazquez-Ortiz wrote 5,638 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 678 | 727 | 106 | $11K |
| Gabapentin Generic | 650 | 801 | 164 | $5,400 |
| Prednisone Generic | 516 | 526 | 143 | $2,882 |
| Hydroxychloroquine Sulfate Generic | 347 | 403 | 61 | $11K |
| Prolia Denosumab | 248 | 1,488 | 169 | $439K |
| Baclofen Generic | 208 | 214 | 74 | $1,545 |
| Alendronate Sodium Generic | 204 | 333 | 59 | $2,184 |
| Duloxetine Hcl Generic | 185 | 203 | 48 | $2,423 |
| Diclofenac Sodium Generic | 169 | 169 | 66 | $3,061 |
| Humira(Cf) Pen Adalimumab | 152 | 152 | 18 | $1.1M |
| Diclofenac Potassium Generic | 150 | 154 | 60 | $5,994 |
| Pregabalin Generic | 132 | 132 | 20 | $1,798 |
| Meloxicam Generic | 123 | 131 | 44 | $592 |
| Tizanidine Hcl Generic | 122 | 122 | 31 | $1,385 |
| Cevimeline Hcl Generic | 118 | 135 | 29 | $11K |
Brand drugs: 1,184 claims; generic drugs: 4,454 claims; opioid claims: 15.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Elena Velazquez-Ortiz $49.4 ($49.4 in general payments such as food, travel and fees) from 2 companies. The largest payer was Abbvie Inc. with $25.51.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.